SIM
TXMD icon

Spark Investment Management’s TherapeuticsMD TXMD Stock Holding History

Spark Investment Management’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-862
Closed -$52K – 57
2020
Q4 		$52K Hold
862
– – 0.04% 52
2020
Q3 		$68K Hold
862
– – 0.09% 44
2020
Q2 		$53K Sell
862
-5,070
-85% -$295K 0.19% 58
2020
Q1 		$314K Buy
5,932
+1,584
+36% +$157K 0.17% 186
2019
Q4 		$526K Buy
+4,348
New +$625K 0.06% 341

Other funds holding TXMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Spark Investment Management's TXMD Position: Q1 2021 in Review

Spark Investment Management sold out of TherapeuticsMD (TXMD) in Q1 2021, closing a stake of 862 shares — an estimated $52K sold.

Spark Investment Management first reported a position in TXMD in Q4 2019 and held it in 5 quarters. The position peaked at $526K in Q4 2019. 160 funds tracked by Wall St. Rank hold TXMD as of Q1 2021.

  • Spark Investment Management reported no remaining TherapeuticsMD position as of Q1 2021 after selling out during the quarter.
  • Spark Investment Management sold 862 TherapeuticsMD shares in Q1 2021, an estimated $52K.
  • Spark Investment Management first reported a position in TherapeuticsMD in Q4 2019 and held it in 5 quarters.
  • Spark Investment Management's TherapeuticsMD position peaked at $526K in Q4 2019.
  • 160 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2021.

Based on Spark Investment Management's 13F filing for Q1 2021, filed 13 May 2021.